cdr

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top

Congratulations to Dr. Kok Yung Lee and Dr. Anna Mueller-Schoell for Winning the Best Presentation Award at the EORTC-PAMM Group Meeting

Published on: 16 Jun 2021 Viewed: 423

The EORTC-PAMM Meeting was successfully held on 21-22 April 2021, and the journal Cancer Drug Resistance supported two awards for the best presentation on each day of the meeting.

We warmly congratulate two outstanding young scholars of Dr. Kok Yung Lee, from Cardiff University, Cardiff, United Kingdom, and Dr. Anna Mueller-Schoell, Institute of Pharmacy, Freie Universitaet Berlin, Germany, for winning the Best Presentation Award at the EORTC-PAMM Group Meeting. Each of them will receive €250 as a reward.

Introduction

 

Dr. Kok Yung Lee (April 21, 2021)

Topic: Overcoming TRAIL resistance in cancer stem cells: Computer-aided discovery of c-FLIP inhibitors

Kok Yung Leea, Andrea Brancalea, Richard Clarksonb, and Andrew Westwella

Affiliations

a School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom, CF10 3NB.
b European Cancer Stem Cell Research Institute, Cardiff University, Cardiff, United Kingdom, CF24 4HQ.

 

Dr. Anna Mueller-Schoell (April 22, 2021)

Topic: A quantitative systems pharmacology model of four CAR-T cell phenotypes and CD19-positive metabolic tumour volume elucidates sources of the large pharmacokinetic variability

Anna Mueller-Schoella,b, Nahum Puebla-Osorioc, Robin Micheleta, Michael Greenc, Annette Kunkeled,e, Wilhelm Huisingaf, Paolo Stratic, Beth Chaseng, Sattva S. Neelapuc, Cassian Yeeh,i, Charlotte Klofta

Affiliations

a Dept. of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Germany
b Graduate Research Training Program PharMetrX, Germany
c Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA
d Charite Universitatmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt – Universitat zu Berlin, and Berlin Institute of Health, Department of Pediatric Oncology and Hematology, Berlin, Germany
e Berlin Institute of Health (BIH), Berlin, Germany
f Institute of Mathematics, University of Potsdam, Potsdam, Germany
g Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, USA
h Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
i Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, USA

For more journal news, welcome to visit https://cdrjournal.com/announcement/index.


© 2016-2021 OAE Publishing Inc., except certain content provided by third parties